# Fortress Biotech, Inc.: Form SCHEDULE 13D/A, filed Jun 3, 2025

- Company: [Fortress Biotech, Inc.](/companies/fbio.md) (CIK 1429260)
- Form: SCHEDULE 13D/A
- Filed: 2025-06-03
- Accepted by EDGAR: Jun 3, 2025, 18:46 ET
- Period: not reported
- Accession: 0001104659-25-056072
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1429260/000110465925056072/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1429260/000110465925056072/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1429260/000110465925056072/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jun 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-056072. Last ingested by Listed: Oct 29, 2026, 17:38 ET. No prices; not investment advice.